-
-
-
-
-
-
-
BioCryst Prices Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Commences $55M Public Offering of Common Stock
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Announces Presentation of Additional Analyses of APeX-1 Clinical Trial of BCX7353 at EAACI
-
-
-
-
-
-
-
BioCryst Pharmaceuticals Commences Public Offering of Common Stock
-
-
-
-
-
-
-
BioCryst Pharmaceuticals Commences Public Offering of Common Stock
-
-
52,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All